3002.49.00.50/Malaria RTS,S Vaccine/Japan

Malaria RTS,S Vaccine from Japan

Recombinant circumsporozoite protein-based vaccine with AS01 adjuvant for Plasmodium falciparum. HTS 3002.49.0050 as other protozoal culture-derived prophylactic.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Declare adjuvant composition; multi-dose vial stability data

• Endemic import quotas may apply; CDC collaboration proof

• Reclass risk if adjuvant dominant to 3003